Literature DB >> 33249048

Exosome-mediated miR-33 transfer induces M1 polarization in mouse macrophages and exerts antitumor effect in 4T1 breast cancer cell line.

Maryam Moradi-Chaleshtori1, Mojgan Bandehpour2, Neda Heidari3, Samira Mohammadi-Yeganeh4, Seyed Mahmoud Hashemi5.   

Abstract

Macrophages are the most abundant tumor-infiltrating immune cells. Macrophages are conventionally classified as M1 or M2 types. M2 type is the dominant phenotype of macrophages in the tumor microenvironment. M2 macrophages support different aspects of tumor development, including tumor formation, growth, and metastasis. MicroRNAs (miRNAs) have been demonstrated to regulate numerous cellular processes, including macrophage polarization. To determine whether miR-33 containing exosomes can alter macrophage polarization, we used the exosomes isolated from 4T1 breast cancer cells to deliver miR-33 mimic into IL-4 induced M2 macrophages and treated macrophages with 4T1-conditioned media. Then, we assayed the expression of M1 specific markers and the production of cytokines using real-time PCR and ELISA, respectively. Additionally, we performed MTT, migration, and invasion assays to detect the effect of miRNA-mediated macrophage repolarization on cancer cell proliferation, migration, and invasion. The results of this study showed that miR-33 containing exosomes could convert M2 to M1 phenotype as indicated by an increase in expression of M1 markers, including Irf5, Nos2, and CD86, and a decrease in M2 markers including Arg, Ym1, and CD206. Furthermore, the secretion of TNF-α and IL-1β as M1 specific cytokines increased, while the secretion of IL-10 and TGF-β as M2 specific cytokines decreased. Incubation of 4T1 cells with conditioned media of treated macrophages showed reduced proliferation, invasion, and migration of these cells. So, our data suggests that exosomes can be used as an efficient nanocarrier for miR-33 delivery into macrophages. Also, miR-33 is capable of inducing M1 polarization in macrophages, which is essential for suppressing tumor growth and metastasis.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  4T1 breast cancer cells; Exosome; Macrophage polarization; miR-33

Mesh:

Substances:

Year:  2020        PMID: 33249048     DOI: 10.1016/j.intimp.2020.107198

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  13 in total

Review 1.  Nano to rescue: repository of nanocarriers for targeted drug delivery to curb breast cancer.

Authors:  Poonam Banthia; Lokesh Gambhir; Asha Sharma; Dhiraj Daga; Neha Kapoor; Rishabh Chaudhary; Gaurav Sharma
Journal:  3 Biotech       Date:  2022-02-13       Impact factor: 2.406

2.  Upregulation of miR-33 Exacerbates Heat-Stress-Induced Apoptosis in Granulosa Cell and Follicular Atresia of Nile Tilapia (Oreochromis niloticus) by Targeting TGFβ1I1.

Authors:  Jun Qiang; Fan-Yi Tao; Qi-Si Lu; Jie He; Pao Xu
Journal:  Genes (Basel)       Date:  2022-06-02       Impact factor: 4.141

3.  Immunotherapy Using Oxygenated Water and Tumor-Derived Exosomes Potentiates Antitumor Immune Response and Attenuates Malignancy Tendency in Mice Model of Breast Cancer.

Authors:  Nafiseh Pakravan; Ardeshir Abbasi; Zuhair Mohammad Hassan
Journal:  Oxid Med Cell Longev       Date:  2021-05-28       Impact factor: 6.543

Review 4.  Non-Coding RNAs in the Crosstalk between Breast Cancer Cells and Tumor-Associated Macrophages.

Authors:  Anna Benedetti; Chiara Turco; Giulia Fontemaggi; Francesco Fazi
Journal:  Noncoding RNA       Date:  2022-02-06

Review 5.  Tendon Immune Regeneration: Insights on the Synergetic Role of Stem and Immune Cells during Tendon Regeneration.

Authors:  Valentina Russo; Mohammad El Khatib; Giuseppe Prencipe; Maria Rita Citeroni; Melisa Faydaver; Annunziata Mauro; Paolo Berardinelli; Adrián Cerveró-Varona; Arlette A Haidar-Montes; Maura Turriani; Oriana Di Giacinto; Marcello Raspa; Ferdinando Scavizzi; Fabrizio Bonaventura; Johannes Stöckl; Barbara Barboni
Journal:  Cells       Date:  2022-01-27       Impact factor: 6.600

Review 6.  Tumor-derived exosomal components: the multifaceted roles and mechanisms in breast cancer metastasis.

Authors:  Yufang Tan; Xiao Luo; Wenchang Lv; Weijie Hu; Chongru Zhao; Mingchen Xiong; Yi Yi; Dawei Wang; Yichen Wang; Haiping Wang; Yiping Wu; Qi Zhang
Journal:  Cell Death Dis       Date:  2021-05-26       Impact factor: 8.469

Review 7.  Extracellular Vesicles as Mediators of Therapy Resistance in the Breast Cancer Microenvironment.

Authors:  Mark Samuels; Chiara Cilibrasi; Panagiotis Papanastasopoulos; Georgios Giamas
Journal:  Biomolecules       Date:  2022-01-14

8.  miR-410-3P inhibits adipocyte differentiation by targeting IRS-1 in cancer-associated cachexia patients.

Authors:  Diya Sun; Zuoyou Ding; Lei Shen; Fan Yang; Jun Han; Guohao Wu
Journal:  Lipids Health Dis       Date:  2021-09-25       Impact factor: 3.876

9.  Highly expressed centromere protein L indicates adverse survival and associates with immune infiltration in hepatocellular carcinoma.

Authors:  Zhili Zeng; Xiao Jiang; Zhibin Pan; Ruisheng Zhou; Zhuangteng Lin; Ying Tang; Ying Cui; Enxin Zhang; Zebiao Cao
Journal:  Aging (Albany NY)       Date:  2021-10-04       Impact factor: 5.682

Review 10.  Exosomes as Emerging Drug Delivery and Diagnostic Modality for Breast Cancer: Recent Advances in Isolation and Application.

Authors:  Dulla Naveen Kumar; Aiswarya Chaudhuri; Farrukh Aqil; Deepa Dehari; Radha Munagala; Sanjay Singh; Ramesh C Gupta; Ashish Kumar Agrawal
Journal:  Cancers (Basel)       Date:  2022-03-10       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.